Nilotinib-induced panniculitis in a patient with chronic myelogenous leukaemia.
Department of Dermatology, Japanese Red Cross Wakayama Medical Center, Wakayama, 640-8558, Japan.|Department of Dermatology, Kyoto University Graduate School of Medicine, 606-8507, Kyoto, Japan.
N
N
Kitayama
Department of Dermatology, Kyoto University Graduate School of Medicine, 606-8507, Kyoto, Japan.
A
A
Otsuka
Department of Dermatology, Japanese Red Cross Wakayama Medical Center, Wakayama, 640-8558, Japan.
C
C
Hamamoto
Department of Dermatology, Kyoto University Graduate School of Medicine, 606-8507, Kyoto, Japan.
Y
Y
Kaku
Department of Hematology, Japanese Red Cross Wakayama Medical Center, 640-8558, Wakayama, Japan.
H
H
Shiragami
Department of Plastic and Reconstructive Surgery, Japanese Red Cross Wakayama Medical Center, 640-8558, Wakayama, Japan.
Y
Y
Okumura
Department of Dermatology, Japanese Red Cross Wakayama Medical Center, Wakayama, 640-8558, Japan.
K
K
Tsujioka
D000368:Aged; D003875:Drug Eruptions / Q000209:etiology*; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy; D008297:Male; D015434:Panniculitis / Q000139:chemically induced*; D011743:Pyrimidines / Q000009:adverse effects* / Q000627:therapeutic use
D011743:Pyrimidines; C498826:nilotinib